- Home
- PROK vs SMID Comparison
PROK vs SMID Comparison
Compare PROK & SMID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- SMID
- Stock Information
- Founded
- PROK 2015
- SMID 1960
- Country
- PROK United States
- SMID United States
- Employees
- PROK N/A
- SMID N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- SMID Building Materials
- Sector
- PROK Health Care
- SMID Industrials
- Exchange
- PROK Nasdaq
- SMID Nasdaq
- Market Cap
- PROK 206.0M
- SMID 166.5M
- IPO Year
- PROK N/A
- SMID 1995
- Fundamental
- Price
- PROK $1.50
- SMID $34.74
- Analyst Decision
- PROK Buy
- SMID
- Analyst Count
- PROK 5
- SMID 0
- Target Price
- PROK $4.50
- SMID N/A
- AVG Volume (30 Days)
- PROK 344.0K
- SMID 14.7K
- Earning Date
- PROK 03-21-2025
- SMID 11-14-2024
- Dividend Yield
- PROK N/A
- SMID N/A
- EPS Growth
- PROK N/A
- SMID 1025.92
- EPS
- PROK N/A
- SMID 1.22
- Revenue
- PROK N/A
- SMID $76,366,000.00
- Revenue This Year
- PROK N/A
- SMID N/A
- Revenue Next Year
- PROK N/A
- SMID N/A
- P/E Ratio
- PROK N/A
- SMID $28.48
- Revenue Growth
- PROK N/A
- SMID 32.40
- 52 Week Low
- PROK $1.34
- SMID $25.03
- 52 Week High
- PROK $4.44
- SMID $51.96
- Technical
- Relative Strength Index (RSI)
- PROK 41.47
- SMID 35.23
- Support Level
- PROK $1.50
- SMID $35.01
- Resistance Level
- PROK $1.67
- SMID $39.77
- Average True Range (ATR)
- PROK 0.10
- SMID 2.30
- MACD
- PROK -0.00
- SMID -0.02
- Stochastic Oscillator
- PROK 10.71
- SMID 10.82
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About SMID Smith-Midland Corporation
Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.